Despite efforts at early revascularization in acute coronary syndrome and advancing
technologies in the field of temporary mechanical circulatory support (TMCS), the mortality …

Cardiogenic shock is a state of tissue hypoperfusion induced by heart failure after correction
of preload. There are no clear numerical cutoffs to define of the hemodynamic parameters of …

Cardiogenic shock (CS) is commonly defined as a physiologic state in which cardiac pump
function is inadequate to perfuse the tissues. If CS is not rapidly recognized and treated …

Cardiogenic shock mortality rates remain high despite significant advances in
cardiovascular medicine and the widespread uptake of mechanical circulatory support …

and management remains challenging despite advances in therapeutic options. CS is
caused by severe impairment of myocardial performance that results in diminished cardiac …

Background: Cardiogenic shock (CS) is a life-threatening state of tissue hypoperfusion,
associated with a very high risk of mortality, despite intensive monitoring and modern …

Aim: Evidence on non-ischemic cardiogenic shock (CS) is scarce. The aim of this study was
to investigate differences in patient characteristics, use of treatments and outcomes in …

Up to 10% of acute coronary syndromes are complicated by cardiogenic shock (CS) with
contemporary mortality rates of 40–50%. The extent of ischemic myocardium has a profound …

Cardiogenic shock (CS) is a dramatic and highly lethal condition that has long presented a
challenge to those who care for patients in the cardiac intensive care unit (CICU). CS …

Cardiogenic shock in the setting of acute myocardial infarction remains a major cause of
morbidity and mortality. In fact, acute myocardial infarction accounts for 81% of patients in …